The Best Investing Strategy into 2024
It’s the time of year where every sell-side analyst gives …
Expect This Retail Stock to Resurge in 2024
I’ve talked before about “mall rats” stocks that have seen …
Insiders Are Buying the Blood in This Biopharma Stock
Take a look at this:
Insiders Are Buying the Blood
Our Stock Roadmap Is Serving Up End-of-Year Profits (Plus Two New Opportunities)
We’re sliding into the home stretch of 2023 with some …
How We’re Leveraging the Largest Misallocation of Capital in Modern Finance
This chart crossed my desk this morning…
Fresh from the …
